Eur J Pediatr Surg 2017; 27(03): 280-287
DOI: 10.1055/s-0036-1592136
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Systemic and Local Cytokine Profile in Biliary Atresia

Takeshi Saito
1   Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba City, Chiba, Japan
,
Akemi Sakamoto
2   Biomedical Research Center, Chiba University, Chiba City, Chiba, Japan
,
Masahiko Hatano
2   Biomedical Research Center, Chiba University, Chiba City, Chiba, Japan
,
Jun Iwai
3   Department of Surgery, Chiba Children's Hospital, Chiba City, Chiba, Japan
,
Yasuyuki Higashimoto
3   Department of Surgery, Chiba Children's Hospital, Chiba City, Chiba, Japan
,
Hideo Yoshida
1   Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba City, Chiba, Japan
› Author Affiliations
Further Information

Publication History

20 March 2016

21 July 2016

Publication Date:
16 September 2016 (online)

Abstract

Purpose Systemic and local immune environments in human biliary atresia (BA) were analyzed.

Methods Plasma concentrations of 19 inflammatory components in 16 preoperative BA patients (median age, 51 days), 13 normal controls (NCs) (44 days), and 15 cholestatic controls (CC) (23 days) were measured using flow cytometry, and compared according to post-Kasai outcomes in BA patients. Hepatic mRNA levels of representative helper T (Th) cell cytokines and forkhead box protein 3 (FoxP3) quantified by real-time reverse transcription polymerase chain reaction were compared between BA and non-BA.

Results No significant differences were observed between BA and control in serum Th1, Th2, or macrophage markers, while soluble cellular adhesion molecule (CAM) levels were significantly higher in BA (p < 0.0001 for NC; p = 0.0003 for CC). No statistically significant difference was discovered between BA with favorable and unfavorable prognosis. Hepatic mRNA levels of interferon-gamma or interleukin-4 showed no significant differences between BA and non-BA, while FoxP3 was significantly higher in BA (p = 0.01).

Conclusions A skewed bias toward specific Th-oriented immunity was not demonstrated in either the systemic or local environment in the early stage of human BA, with patient prognoses not necessarily revealed by preoperative plasma inflammatory component levels. CAM and regulatory T cell roles and functions warrant further investigation.

 
  • References

  • 1 Riepenhoff-Talty M, Gouvea V, Evans MJ. , et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996; 174 (01) 8-15
  • 2 Tyler KL, Sokol RJ, Oberhaus SM. , et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998; 27 (06) 1475-1482
  • 3 Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation”. Hepatology 1992; 16 (04) 1069-1083
  • 4 Suskind DL, Rosenthal P, Heyman MB. , et al. Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol 2004; 4: 14
  • 5 Petersen C, Davenport M. Aetiology of biliary atresia: what is actually known?. Orphanet J Rare Dis 2013; 8: 128
  • 6 Shivakumar P, Campbell KM, Sabla GE. , et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004; 114 (03) 322-329
  • 7 Mack CL, Tucker RM, Lu BR. , et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006; 44 (05) 1231-1239
  • 8 Bezerra JA, Tiao G, Ryckman FC. , et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002; 360 (9346): 1653-1659
  • 9 Mack CL, Tucker RM, Sokol RJ. , et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004; 56 (01) 79-87
  • 10 Li J, Bessho K, Shivakumar P. , et al. Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest 2011; 121 (11) 4244-4256
  • 11 Shinkai M, Shinkai T, Puri P, Stringer MD. Elevated expression of IL2 is associated with increased infiltration of CD8+ T cells in biliary atresia. J Pediatr Surg 2006; 41 (02) 300-305
  • 12 Nobili V, Marcellini M, Giovannelli L. , et al. Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease. J Pediatr Gastroenterol Nutr 2004; 39 (05) 540-544
  • 13 Wu JF, Kao PC, Chen HL. , et al. A high serum interleukin-12p40 level prior to Kasai surgery predict a favourable outcome in children with biliary atresia. Liver Int 2012; 32 (10) 1557-1563
  • 14 Urushihara N, Iwagaki H, Yagi T. , et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000; 35 (03) 446-449
  • 15 Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M. Serial circulating markers of inflammation in biliary atresia—evolution of the post-operative inflammatory process. Hepatology 2007; 46 (01) 180-187
  • 16 Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133 (05) 775-787
  • 17 Lan RY, Cheng C, Lian ZX. , et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006; 43 (04) 729-737
  • 18 Sakaki M, Hiroishi K, Baba T. , et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 2008; 38 (04) 354-361
  • 19 Yang Y, Liu YJ, Tang ST. , et al. Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia. Pediatr Surg Int 2013; 29 (12) 1249-1260
  • 20 Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology 2012; 55 (04) 1130-1138
  • 21 Uchida K, Inoue M, Otake K. , et al. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia. J Pediatr Surg 2006; 41 (10) 1657-1662
  • 22 Vejchapipat P, Poomsawat S, Chongsrisawat V, Honsawek S, Poovorawan Y. Elevated serum IL-18 and interferon-gamma in medium-term survivors of biliary atresia. Eur J Pediatr Surg 2012; 22 (01) 29-33
  • 23 Dong R, Dong K, Wang X, Chen G, Shen C, Zheng S. Interleukin-33 overexpression is associated with gamma-glutamyl transferase in biliary atresia. Cytokine 2013; 61 (02) 433-437
  • 24 Bessho K, Mourya R, Shivakumar P. , et al. Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology 2014; 60 (01) 211-223
  • 25 Davenport M, Gonde C, Narayanaswamy B, Mieli-Vergani G, Tredger JM. Soluble adhesion molecule profiling in preoperative infants with biliary atresia. J Pediatr Surg 2005; 40 (09) 1464-1469
  • 26 Minnick KE, Kreisberg R, Dillon PW. Soluble ICAM-1 (sICAM-1) in biliary atresia and its relationship to disease activity. J Surg Res 1998; 76 (01) 53-56
  • 27 Ghoneim EM, Sira MM, Abd Elaziz AM, Khalil FO, Sultan MM, Mahmoud AB. Diagnostic value of hepatic intercellular adhesion molecule-1 expression in Egyptian infants with biliary atresia and other forms of neonatal cholestasis. Hepatol Res 2011; 41 (08) 763-775
  • 28 Fenoglio D, Bernuzzi F, Battaglia F. , et al. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev 2012; 12 (02) 300-304
  • 29 Beriou G, Costantino CM, Ashley CW. , et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113 (18) 4240-4249
  • 30 Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112 (06) 2340-2352